Correlation Between Standard Biotools and RAPT Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Standard Biotools and RAPT Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Standard Biotools and RAPT Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Standard Biotools and RAPT Therapeutics, you can compare the effects of market volatilities on Standard Biotools and RAPT Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Standard Biotools with a short position of RAPT Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Standard Biotools and RAPT Therapeutics.

Diversification Opportunities for Standard Biotools and RAPT Therapeutics

0.62
  Correlation Coefficient

Poor diversification

The 3 months correlation between Standard and RAPT is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Standard Biotools and RAPT Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RAPT Therapeutics and Standard Biotools is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Standard Biotools are associated (or correlated) with RAPT Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RAPT Therapeutics has no effect on the direction of Standard Biotools i.e., Standard Biotools and RAPT Therapeutics go up and down completely randomly.

Pair Corralation between Standard Biotools and RAPT Therapeutics

Considering the 90-day investment horizon Standard Biotools is expected to generate 1.34 times more return on investment than RAPT Therapeutics. However, Standard Biotools is 1.34 times more volatile than RAPT Therapeutics. It trades about 0.08 of its potential returns per unit of risk. RAPT Therapeutics is currently generating about -0.07 per unit of risk. If you would invest  145.00  in Standard Biotools on October 13, 2025 and sell it today you would earn a total of  9.00  from holding Standard Biotools or generate 6.21% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Standard Biotools  vs.  RAPT Therapeutics

 Performance 
       Timeline  
Standard Biotools 

Risk-Adjusted Performance

Mild

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Standard Biotools are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Standard Biotools sustained solid returns over the last few months and may actually be approaching a breakup point.
RAPT Therapeutics 

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in RAPT Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, RAPT Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Standard Biotools and RAPT Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Standard Biotools and RAPT Therapeutics

The main advantage of trading using opposite Standard Biotools and RAPT Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Standard Biotools position performs unexpectedly, RAPT Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RAPT Therapeutics will offset losses from the drop in RAPT Therapeutics' long position.
The idea behind Standard Biotools and RAPT Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments